RNA - Avidity Biosciences Inc
IEX Last Trade
43.93
1.290 2.936%
Share volume: 1,094,696
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$42.64
1.29
3.03%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-02-28 | 2023-05-09 | 2023-08-08 | 2023-11-08 | 2024-02-28 | 2024-05-09 | |
| Total revenue | 2.178 M | 2.482 M | 2.769 M | 2.233 M | 2.316 M | 2.818 M | 2.193 M | 3.543 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 2.178 M | 2.482 M | 2.769 M | 2.233 M | 2.316 M | 2.818 M | 2.193 M | 3.543 M | |
| 13.96% | 11.56% | -19.36% | 3.72% | 21.68% | -22.18% | 61.56% | |||
| Operating expenses | 48.477 M | 47.411 M | 55.994 M | 59.829 M | 54.950 M | 61.443 M | 68.936 M | 80.730 M | |
| Selling general and admin | 8.688 M | 10.094 M | 10.384 M | 12.064 M | 12.278 M | 13.729 M | 16.119 M | 13.898 M | |
| Research and development | 39.789 M | 37.317 M | 45.610 M | 47.765 M | 42.672 M | 47.714 M | 52.817 M | 66.832 M | |
| Total expenses | 48.477 M | 47.411 M | 55.994 M | 59.829 M | 54.950 M | 61.443 M | 68.936 M | 80.730 M | |
| -2.20% | 18.10% | 6.85% | -8.15% | 11.82% | 12.20% | 17.11% | |||
| Operating income | -46.299 M | -44.929 M | -53.225 M | -57.596 M | -52.634 M | -58.625 M | -66.743 M | -77.187 M | |
| Ebit | -46.299 M | -44.929 M | -53.225 M | -57.596 M | -52.634 M | -58.625 M | -66.743 M | -77.187 M | |
| Pretax income | -45.690 M | -43.599 M | -50.471 M | -52.394 M | -47.025 M | -52.358 M | -60.443 M | -68.855 M | |
| -4.58% | 15.76% | 3.81% | -10.25% | 11.34% | 15.44% | 13.92% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -45.690 M | -43.599 M | -50.471 M | -52.394 M | -47.025 M | -52.358 M | -60.443 M | -68.855 M | |
| 4.58% | -15.76% | -3.81% | 10.25% | -11.34% | -15.44% | -13.92% | |||
| Net income | -45.690 M | -43.599 M | -50.471 M | -52.394 M | -47.025 M | -52.358 M | -60.443 M | -68.855 M | |
| 4.58% | -15.76% | -3.81% | 10.25% | -11.34% | -15.44% | -13.92% |